17 November 2020 - The evidence shows only that the drug might be effective. That once wasn’t enough for FDA approval.

When the FDA approves a new treatment or vaccine, as doctors we are assured that rigorous studies have proven it to be safe and effective. 

But the FDA’s haphazard issuance of emergency use authorisations for COVID-19 treatments like hydroxychloroquine and convalescent plasma, whose potential benefits have not yet been backed up by data, has undermined this trust.

Read New York Times Opinion